The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Immunohistochemical Assessment of the Glial Mitogen-Activated Protein Kinase Activation in Glaucoma
Abstract
PURPOSE: To determine whether retinal glial cells exhibit an activated phenotype in glaucomatous human eyes and whether the mitogen-activated protein kinases (MAPKs) are associated with glial activation in glaucoma. METHODS: Activated phenotypes of retinal macroglia (astrocytes and Müller cells) and microglia were identified by morphologic assessment and immunostaining for the cell markers glial fibrillary acidic protein (GFAP) and HLA-DR, respectively, in 30 eyes obtained from glaucomatous donor eyes in comparison with normal control eyes from 20 age-matched donors. Cellular localization of the activated forms of MAPKs, including extracellular signal-regulated kinases (ERK), c-Jun amino(N)-terminal kinase (JNK), and p38, were studied in the retina of these eyes by immunoperoxidase staining and double immunofluorescence labeling with phosphorylation site-specific antibodies. RESULTS: Retinal astrocytes and Müller cells exhibited a hypertrophic morphology and increased immunostaining for GFAP in the glaucomatous retina. Although an increase was detectable in the number and size of cells positive for HLA-DR immunostaining in the glaucomatous retina compared with the control retina, microglial activation was not as prominent or widespread as the macroglial activation detected in the same eyes. The intensity of immunostaining and the number of immunostained cells for the activated MAPKs were greater in retina sections from glaucomatous eyes than in control eyes, being most prominent for phospho-ERK. Double immunofluorescence labeling demonstrated that the increased retinal immunostaining for phospho-ERK was predominantly, but not exclusively, localized to glial cells, whereas, the immunostaining for phospho-JNK or phospho-p38 was mainly associated with nonglial cells. CONCLUSIONS: These findings provide evidence that retinal glial cells undergo activation in the glaucomatous human retina. A prominent and persistent activation of ERK in activated glial cells suggests that this signaling pathway is probably associated with the induction and/or maintenance of the activated glial phenotype in glaucoma. Because MAPKs are involved in determination of ultimate cell fate, their differential activity in neuronal and activated glial cells in the glaucomatous retina may be associated, in part, with the differential susceptibility of these cell types to glaucomatous injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, Z.-G., Hsu, H., Goeddel, D. V., & Karin, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81375-6 · Cited by 1,937
Cited by
Müller cells in the healthy and diseased retina
BRINGMANN, A., PANNICKE, T., GROSCHE, J., FRANCKE, M., WIEDEMANN, P., SKATCHKOV, S., OSBORNE, N., & REICHENBACH, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,711
The molecular basis of retinal ganglion cell death in glaucoma
Almasieh, M., Wilson, A. M., Morquette, B., Cueva Vargas, J. L., & Di Polo, A. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.11.002 · Cited by 971
Bringmann, A., Iandiev, I., Pannicke, T., Wurm, A., Hollborn, M., Wiedemann, P., Osborne, N. N., & Reichenbach, A. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.07.001 · Cited by 761
Oxidative stress in glaucomatous neurodegeneration: Mechanisms and consequences
Tezel, G. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.07.003 · Cited by 723
Self-citationPara-Inflammation in the Aging Retina
Xu, H., Chen, M., & Forrester, J. V. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.06.001 · Cited by 659
Inflammation in Glaucoma: From the back to the front of the eye, and beyond
Baudouin, C., Kolko, M., Melik-Parsadaniantz, S., & Messmer, E. M. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100916 · Cited by 454
Nakazawa, T., Nakazawa, C., Matsubara, A., Noda, K., Hisatomi, T., She, H., Michaud, N., Hafezi-Moghadam, A., Miller, J. W., & Benowitz, L. I. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2801-06.2006 · Cited by 436
Bosco, A., Inman, D. M., Steele, M. R., Wu, G., Soto, I., Marsh-Armstrong, N., Hubbard, W. C., Calkins, D. J., Horner, P. J., & Vetter, M. L. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1337 · Cited by 323
Expression of Apoptosis Markers in the Retinas of Human Subjects with Diabetes
El-Asrar, A. M. A., Dralands, L., Missotten, L., Al-Jadaan, I. A., & Geboes, K. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-1392 · Cited by 292
Gallego, B. I., Salazar, J. J., de Hoz, R., Rojas, B., Ramírez, A. I., Salinas-Navarro, M., Ortín-Martínez, A., Valiente-Soriano, F. J., Avilés-Trigueros, M., Villegas-Perez, M. P., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-92 · Cited by 224
Retinal Macroglial Responses in Health and Disease
de Hoz, R., Rojas, B., Ramírez, A. I., Salazar, J. J., Gallego, B. I., Triviño, A., & Ramírez, J. M. (2016) · BioMed Research International · doi:10.1155/2016/2954721 · Cited by 187
Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury
Syc-Mazurek, S. B., Fernandes, K. A., Wilson, M. P., Shrager, P., & Libby, R. T. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0214-8 · Cited by 74
Repici, M., Centeno, C., Tomasi, S., Forloni, G., Bonny, C., Vercelli, A., & Borsello, T. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.08.021 · Cited by 81
Proximal inhibition of p38 MAPK stress signaling prevents distal axonopathy
Dapper, J. D., Crish, S. D., Pang, I.-H., & Calkins, D. J. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.07.001 · Cited by 76
“Increased p38 MAPK signaling has also been documented in human glaucomatous tissue (Tezel et al., 2003).”
More than meets the eye: The role of microglia in healthy and diseased retina
Murenu, E., Gerhardt, M.-J., Biel, M., & Michalakis, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1006897 · Cited by 73
JUN is important for ocular hypertension-induced retinal ganglion cell degeneration
Syc-Mazurek, S. B., Fernandes, K. A., & Libby, R. T. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.338 · Cited by 53
Groeger, G., Doonan, F., Cotter, T. G., & Donovan, M. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10525 · Cited by 45
ERK1/2 signaling pathway in the release of VEGF from Müller cells in diabetes
Ye, X., Ren, H., Zhang, M., Sun, Z., Jiang, A. C., & Xu, G. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-9076 · Cited by 44
Fixation strategies for retinal immunohistochemistry
Stradleigh, T. W., & Ishida, A. T. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.04.001 · Cited by 36
Gao, F., Li, F., Miao, Y., Xu, L.-J., Zhao, Y., Li, Q., Zhang, S.-H., Wu, J., Sun, X.-H., & Wang, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-01557-y · Cited by 34
Mangiferin Protects Retinal Ganglion Cells in Ischemic Mouse Retina via SIRT1
Kim, S.-J., Sung, M.-S., Heo, H., Lee, J.-H., & Park, S.-W. (2016) · Current Eye Research · doi:10.3109/02713683.2015.1050736 · Cited by 33
Syc-Mazurek, S. B., Rausch, R. L., Fernandes, K. A., Wilson, M. P., & Libby, R. T. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-1079-7 · Cited by 29
Harder, J. M., Williams, P. A., Soto, I., Foxworth, N. E., Fernandes, K. A., Freeburg, N. F., Libby, R. T., & John, S. W. M. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0705-8 · Cited by 23
Zeng, S., Zhang, T., Chen, Y., Chu-Tan, J., Jin, K., Lee, S.-R., Yam, M. X., Madigan, M. C., Fernando, N., Cioanca, A., et al. (2022) · Theranostics · doi:10.7150/thno.71038 · Cited by 22
(2010) · PubMed Central · Cited by 22
Lambert, W. S., Pasini, S., Collyer, J. W., Formichella, C. R., Ghose, P., Carlson, B. J., & Calkins, D. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-65374-6 · Cited by 21
Mammone, T., Chidlow, G., Casson, R. J., & Wood, J. P. M. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.01.002 · Cited by 18
Jang, S. Y., Yang, J. Y., Park, J. H., Kim, Y., An, S., Jung, W. H., Park, J.-W., Han, J. W., Kim, J. H., Park, H. S., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062585 · Cited by 7
ERK1/2 pathway is activated in degenerated Rpe65-deficient mice
Métrailler, S., Emery, M., Schorderet, D. F., Cottet, S., & Roduit, R. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.08.015 · Cited by 5
Metadata
- Authors
- Tezel, G., Chauhan, B. C., LeBlanc, R. P., & Wax, M. B.
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2003-07-01
- Volume
- 44
- Issue
- 7
- Pages
- 3025
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W1558237074
- Cited by
- 219
- References
- 1
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.